MiR-204-5p Inhibits Transforming Growth Factor-β1-Induced Proliferation and Extracellular Matrix Production of Airway Smooth Muscle Cells by Regulating Six1 in Asthma
- 1 April 2020
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 181 (4), 239-248
- https://doi.org/10.1159/000505064
Abstract
Background: Transforming growth factor-beta 1 (TGF-beta 1)-in-duced proliferation of airway smooth muscle cells plays critical roles in the development of airway remodeling. Six1 (sine oculis homeobox homolog 1) has been demonstrated to be involved in airway inflammation and remodeling in asthmatic mice. Objectives: The aim of this work was to investigate the potential role of miR-204-5p in the proliferation and extracellular matrix (ECM) production of airway smooth muscle cells in asthma. Methods: Real-time PCR was used to measure the expression of miR-204-5p in asthmatic airway smooth muscle cells. Cell viability and apoptosis were detected to evaluate the effect of miR-204-5p on airway smooth muscle cells. Dual-luciferase reporter experiments were applied to identify the target genes of miR-204-5p. Results: MiR-204-5p was downregulated notably in asthmatic airway smooth muscle cells as well as cells stimulated with TGF-beta 1. Overexpression of miR-204-5p markedly suppressed the TGF-beta 1-induced proliferation of airway smooth muscle cells and the deposition of ECM, whereas the inhibition of miR-204-5p significantly enhanced the proliferation of airway smooth muscle cells and upregulated the level of fibronectin and collagen III. Furthermore, subsequent analyses demonstrated that Six1 was a direct target of miR-204-5p, and Western blot further indicated that miR-204-5p negatively regulated the expression of Six1. Most importantly, the restoration of Six1 expression reversed the inhibitory effect of miR-204-5p on TGF-beta 1-induced proliferation and ECM production. Conclusions: MiR-204-5p inhibits TGF-beta 1-in-duced proliferation and ECM production of airway smooth muscle cells by regulating Six1, identifying a potential therapeutic target for preventing airway remodeling in asthma.This publication has 28 references indexed in Scilit:
- SIX1 maintains tumor basal cells via transforming growth factor‐β pathway and associates with poor prognosis in esophageal cancerCancer Science, 2016
- miR-204 regulates epithelial-mesenchymal transition by targeting SP1 in the tubular epithelial cells after acute kidney injury induced by ischemia-reperfusionOncology Reports, 2016
- RETRACTED: Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic miceBiomedicine & Pharmacotherapy, 2016
- A HuR/TGF-β1 feedback circuit regulates airway remodeling in airway smooth muscle cellsRespiratory Research, 2016
- MiR-23b controls TGF-β1 induced airway smooth muscle cell proliferation via TGFβR2/p-Smad3 signalsMolecular Immunology, 2016
- RETRACTED: miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancerJournal of Cellular and Molecular Medicine, 2016
- MiR-21 modulates human airway smooth muscle cell proliferation and migration in asthma through regulation of PTEN expressionExperimental Lung Research, 2015
- MiR-204-5p/Six1 feedback loop promotes epithelial–mesenchymal transition in breast cancerTumor Biology, 2015
- MicroRNA-204-5p Regulates Epithelial-to-Mesenchymal Transition during Human Posterior Capsule Opacification by Targeting SMAD4Investigative Ophthalmology & Visual Science, 2013
- Inhibition airway remodeling and transforming growth factor-β1/Smad signaling pathway by astragalus extract in asthmatic miceInternational Journal of Molecular Medicine, 2011